4Parkin DM,Bray F.Ferlay J,et al.Global cancer statistics,2002[J].CA Cancer J Clin,2005,55:74-108.
5Bruix J,Sherman M.Management of hepatocellular carcinoma[J].Hepatology,2005,42:1208-1236.
6Germanil G,Pleguezuelo M,Gurusamy K,et al.Clinical outcomes of radiofrequency ablation,percutaneous alcohol and acetic acid injection for hepatocelullar carcinoma:a meta-analy-sis[J].J Hepatol,2010,52:380-388.
7Bouza C,Lopez-Cuadrado T,Alcázar R,et al.Meta-analysis of percutaneous radiofrequency ablation versus ethanol injection in hepatocellular carcinoma[J].BMC Gastroenterol,2009,9:31.
8Kudo M.Radiofrequency ablation for hepatocellular carcinoma:updated review in 2010[J].Oncology,2010,78 (suppl 1):113-124.
9Hasegawa K,Makuuchi M,Takayama T,et al.Surgical resection vs.percutaneous ablation for hepatocellularcarcinoma:a preliminary report of the Japanese nationwide survey[J].J Hepatol,2008,49:589-594.
10Limquiaco JL,Fernandes M,Lin CJ,et al.Radiofrequency ablation for hepatocellular carcinoma:artificial ascites for tumors in high-risk locations improves survival[J].Hepatol Int,2009,3:68.